Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 16 | 2022 | 2934 | 2.020 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2020 | 506 | 0.960 |
Why?
|
Norway | 9 | 2021 | 456 | 0.920 |
Why?
|
Registries | 5 | 2018 | 7989 | 0.840 |
Why?
|
Minerals | 1 | 2019 | 267 | 0.650 |
Why?
|
Cod Liver Oil | 1 | 2015 | 9 | 0.580 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 212 | 0.520 |
Why?
|
Sodium, Dietary | 1 | 2017 | 409 | 0.510 |
Why?
|
Body Size | 1 | 2017 | 466 | 0.500 |
Why?
|
Premature Birth | 2 | 2021 | 1498 | 0.490 |
Why?
|
Physical Fitness | 1 | 2017 | 706 | 0.450 |
Why?
|
Uric Acid | 1 | 2018 | 712 | 0.450 |
Why?
|
Cholecalciferol | 1 | 2015 | 482 | 0.390 |
Why?
|
Menopause | 1 | 2018 | 1518 | 0.390 |
Why?
|
Neurofilament Proteins | 3 | 2022 | 350 | 0.370 |
Why?
|
Vitamin D | 3 | 2020 | 3138 | 0.360 |
Why?
|
Demyelinating Diseases | 2 | 2022 | 368 | 0.350 |
Why?
|
Sex Characteristics | 1 | 2018 | 2510 | 0.320 |
Why?
|
Smoking | 3 | 2020 | 8612 | 0.320 |
Why?
|
Exercise | 3 | 2021 | 5251 | 0.320 |
Why?
|
Diet | 3 | 2019 | 7392 | 0.310 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3565 | 0.290 |
Why?
|
Infectious Mononucleosis | 2 | 2016 | 143 | 0.280 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2022 | 534 | 0.280 |
Why?
|
Risk | 5 | 2019 | 9641 | 0.280 |
Why?
|
Parkinson Disease | 1 | 2018 | 2578 | 0.260 |
Why?
|
Body Mass Index | 3 | 2022 | 12366 | 0.260 |
Why?
|
Cognition | 1 | 2020 | 5982 | 0.240 |
Why?
|
Cotinine | 2 | 2020 | 195 | 0.230 |
Why?
|
Dietary Supplements | 1 | 2015 | 3025 | 0.230 |
Why?
|
Hepatitis E virus | 1 | 2022 | 71 | 0.220 |
Why?
|
Hepatitis E | 1 | 2022 | 72 | 0.220 |
Why?
|
Case-Control Studies | 10 | 2021 | 21194 | 0.220 |
Why?
|
Ribavirin | 1 | 2022 | 396 | 0.200 |
Why?
|
Preconception Care | 1 | 2021 | 128 | 0.200 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2020 | 1345 | 0.200 |
Why?
|
Phosphorus, Dietary | 1 | 2019 | 23 | 0.190 |
Why?
|
Intuition | 1 | 2018 | 14 | 0.180 |
Why?
|
Potassium, Dietary | 1 | 2019 | 93 | 0.180 |
Why?
|
Infant, Small for Gestational Age | 1 | 2021 | 425 | 0.180 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2022 | 276 | 0.170 |
Why?
|
Iron, Dietary | 1 | 2019 | 134 | 0.170 |
Why?
|
Time | 1 | 2020 | 526 | 0.170 |
Why?
|
Young Adult | 10 | 2022 | 55940 | 0.160 |
Why?
|
Validation Studies as Topic | 1 | 2017 | 167 | 0.160 |
Why?
|
Herpesvirus 4, Human | 2 | 2022 | 1241 | 0.160 |
Why?
|
Infant Mortality | 1 | 2021 | 740 | 0.150 |
Why?
|
Gout Suppressants | 1 | 2018 | 167 | 0.150 |
Why?
|
Cohort Studies | 10 | 2022 | 39292 | 0.150 |
Why?
|
Birth Weight | 2 | 2021 | 1893 | 0.150 |
Why?
|
Manganese | 1 | 2019 | 400 | 0.150 |
Why?
|
Copper | 1 | 2019 | 388 | 0.150 |
Why?
|
Calcium, Dietary | 1 | 2019 | 518 | 0.150 |
Why?
|
Gestational Age | 2 | 2021 | 3378 | 0.150 |
Why?
|
Epidemiology | 1 | 2018 | 289 | 0.140 |
Why?
|
Science | 1 | 2018 | 246 | 0.140 |
Why?
|
Adolescent | 9 | 2022 | 84718 | 0.140 |
Why?
|
Child of Impaired Parents | 1 | 2019 | 454 | 0.140 |
Why?
|
Magnesium | 1 | 2019 | 852 | 0.140 |
Why?
|
Antibodies, Viral | 3 | 2022 | 2930 | 0.130 |
Why?
|
Zinc | 1 | 2019 | 682 | 0.130 |
Why?
|
Risk Factors | 13 | 2022 | 69553 | 0.130 |
Why?
|
Adjuvants, Immunologic | 1 | 2020 | 954 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2020 | 1192 | 0.130 |
Why?
|
Female | 22 | 2022 | 375205 | 0.130 |
Why?
|
Middle Aged | 13 | 2021 | 213752 | 0.130 |
Why?
|
Child Abuse | 1 | 2022 | 979 | 0.120 |
Why?
|
Disability Evaluation | 1 | 2021 | 1829 | 0.120 |
Why?
|
Adult | 16 | 2022 | 211041 | 0.120 |
Why?
|
Prospective Studies | 6 | 2022 | 50597 | 0.120 |
Why?
|
Humans | 29 | 2022 | 708843 | 0.120 |
Why?
|
Breast Feeding | 1 | 2021 | 1273 | 0.120 |
Why?
|
Mothers | 2 | 2021 | 1991 | 0.110 |
Why?
|
Nurses | 2 | 2021 | 2370 | 0.110 |
Why?
|
Databases, Factual | 2 | 2018 | 7763 | 0.110 |
Why?
|
Ritonavir | 1 | 2013 | 301 | 0.110 |
Why?
|
HIV Protease Inhibitors | 1 | 2013 | 435 | 0.100 |
Why?
|
Follow-Up Studies | 4 | 2022 | 39038 | 0.100 |
Why?
|
Pregnancy | 5 | 2022 | 26832 | 0.100 |
Why?
|
Male | 16 | 2022 | 349524 | 0.090 |
Why?
|
Age Factors | 2 | 2018 | 18712 | 0.090 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13536 | 0.090 |
Why?
|
Aged | 7 | 2021 | 161488 | 0.080 |
Why?
|
Mental Health | 1 | 2021 | 2602 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 3354 | 0.080 |
Why?
|
Cytomegalovirus | 2 | 2022 | 681 | 0.080 |
Why?
|
Migraine Disorders | 1 | 2017 | 1411 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 1925 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2020 | 11877 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 11239 | 0.070 |
Why?
|
Incidence | 2 | 2019 | 20320 | 0.060 |
Why?
|
Infant | 2 | 2021 | 34261 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12292 | 0.060 |
Why?
|
Mutagens | 1 | 2022 | 168 | 0.060 |
Why?
|
Aging | 1 | 2021 | 8358 | 0.060 |
Why?
|
Infant, Newborn | 1 | 2021 | 24433 | 0.050 |
Why?
|
Asthma | 1 | 2019 | 5850 | 0.050 |
Why?
|
Quality of Life | 1 | 2021 | 11594 | 0.050 |
Why?
|
Nucleotides | 1 | 2022 | 440 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5348 | 0.050 |
Why?
|
Maternal Age | 1 | 2021 | 774 | 0.040 |
Why?
|
Finland | 1 | 2019 | 584 | 0.040 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2019 | 267 | 0.040 |
Why?
|
Brazil | 1 | 2019 | 1129 | 0.040 |
Why?
|
Diet Surveys | 1 | 2019 | 1157 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2018 | 58184 | 0.030 |
Why?
|
Italy | 1 | 2017 | 744 | 0.030 |
Why?
|
Food | 1 | 2019 | 708 | 0.030 |
Why?
|
Age of Onset | 1 | 2022 | 3330 | 0.030 |
Why?
|
Sweden | 1 | 2017 | 1290 | 0.030 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 2013 | 24 | 0.030 |
Why?
|
Reference Values | 1 | 2021 | 5041 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3518 | 0.030 |
Why?
|
Military Personnel | 1 | 2022 | 1050 | 0.030 |
Why?
|
Logistic Models | 2 | 2020 | 13468 | 0.030 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2013 | 111 | 0.030 |
Why?
|
United States | 2 | 2018 | 67165 | 0.030 |
Why?
|
Women's Health | 1 | 2021 | 1898 | 0.030 |
Why?
|
Midazolam | 1 | 2013 | 252 | 0.030 |
Why?
|
Europe | 1 | 2016 | 3104 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8255 | 0.020 |
Why?
|
Child | 3 | 2022 | 73636 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2021 | 2290 | 0.020 |
Why?
|
Lipids | 1 | 2020 | 3246 | 0.020 |
Why?
|
Area Under Curve | 1 | 2013 | 1688 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2278 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2019 | 4422 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2806 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 14712 | 0.020 |
Why?
|
Disease Progression | 1 | 2022 | 13298 | 0.020 |
Why?
|
Odds Ratio | 1 | 2016 | 9754 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 23020 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12031 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 10857 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23284 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 34151 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 71483 | 0.010 |
Why?
|
Concepts
(137)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_